| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1212/01.WNL.0000259085.61898.9E |
| P698 | PubMed publication ID | 17420400 |
| P50 | author | Robert H Dworkin | Q97303759 |
| P2093 | author name string | Mark P Jensen | |
| Marci J Chodroff | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropathic pain | Q2798704 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 1178-1182 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The impact of neuropathic pain on health-related quality of life: review and implications | |
| P478 | volume | 68 |
| Q37362035 | "Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes |
| Q35685828 | 2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling. |
| Q34470394 | A classification of chronic pain for ICD-11. |
| Q43662938 | A meta-analytic approach to estimating nocebo effects in neuropathic pain trials. |
| Q37398389 | A novel nonpharmacological intervention - breathing-controlled electrical stimulation for neuropathic pain management after spinal cord injury - a preliminary study |
| Q37476375 | A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial. |
| Q36628308 | A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain |
| Q37062479 | A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions |
| Q26995876 | Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials |
| Q34083886 | Acupuncture and chiropractic care for chronic pain in an integrated health plan: a mixed methods study |
| Q28581388 | Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats |
| Q59792976 | Altered pain processing in people with type I and II diabetes: a protocol for a systematic review and meta-analysis of pain threshold and pain modulation mechanisms |
| Q39082182 | Application of the Rat Grimace Scale as a Marker of Supraspinal Pain Sensation after Cervical Spinal Cord Injury. |
| Q36687424 | Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire? |
| Q51305254 | Assessment and management of neuropathic pain in primary care. |
| Q38224181 | Assessment of physical activity of patients with chronic pain |
| Q37517378 | Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial |
| Q37129948 | Association between Neuropathic Pain and Reported Disability after Total Knee Arthroplasty |
| Q30251984 | Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis. |
| Q47839795 | Association between pain, central sensitization and anxiety in postherpetic neuralgia |
| Q37232433 | Association of neuropathic pain with ultrasonographic measurements of femoral cartilage thickness and clinical parameters in patients with knee osteoarthritis |
| Q55388766 | Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting. |
| Q39209726 | Best practices in the treatment of neuropathic pain |
| Q35584564 | Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis |
| Q82465942 | Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010 |
| Q34785937 | Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain |
| Q35905862 | Breathing-controlled electrical stimulation could modify the affective component of neuropathic pain after amputation: a case report |
| Q36600465 | Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey |
| Q35901628 | Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist |
| Q57148532 | Cannabinoid Delivery Systems for Pain and Inflammation Treatment |
| Q36213567 | Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. |
| Q47728794 | Care for Adults with Spina Bifida: Current State and Future Directions |
| Q33810343 | Central neuropathic pain after cerebral venous thrombosis is not so uncommon: an observational study |
| Q37579382 | Central post-stroke pain: clinical characteristics, pathophysiology, and management |
| Q39246158 | Cetuximab alleviates neuropathic pain despite tumour progression |
| Q41074333 | Changes in pain and quality of life in depressed individuals with spinal cord injury: does type of pain matter? |
| Q94368048 | Chronic Orofacial Pain: Burning Mouth Syndrome and Other Neuropathic Disorders |
| Q40514798 | Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross-Sectional Evaluation in Pain Clinics. |
| Q92955855 | Clinical characteristics of neuropathic pain in leprosy and associated somatosensory profiles: a deep phenotyping study in India |
| Q36245963 | Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy |
| Q58792130 | Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study |
| Q35223920 | Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice |
| Q44456466 | Comparison of gabapentin versus topiramate on clinically affected dogs with Chiari-like malformation and syringomyelia. |
| Q33937485 | Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice |
| Q36432810 | Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics? |
| Q34936623 | Consideration of chronic pain in trials to promote physical activity for diabetes: a systematic review of randomized controlled trials |
| Q51419600 | Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain. |
| Q37630964 | Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the korean diabetes association. |
| Q37267129 | Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study |
| Q37444829 | Developing Core Sets for persons following amputation based on the International Classification of Functioning, Disability and Health as a way to specify functioning |
| Q39259411 | Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting |
| Q92855889 | Dextromethorphan and memantine after ketamine analgesia: a randomized control trial |
| Q36172356 | Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats |
| Q60684386 | Distinguishing between nociceptive and neuropathic components in chronic low back pain using behavioural evaluation and sensory examination |
| Q46083221 | Dorsal Horn Parvalbumin Neurons Are Gate-Keepers of Touch-Evoked Pain after Nerve Injury. |
| Q35619182 | Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy |
| Q90982625 | Douleur Neuropathique 4 (DN4) stratifies possible and definite neuropathic pain after surgical peripheral nerve lesion |
| Q21261358 | Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials |
| Q34110857 | EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision |
| Q34795362 | Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States |
| Q37683352 | Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice |
| Q40127495 | Effects of Pain and Pain Management on Motor Recovery of Spinal Cord-Injured Patients: A Longitudinal Study |
| Q61814503 | Effects of extracorporeal shock waves on neuralgia in diabetic rats |
| Q41232343 | Effects of β2 agonists on post-thoracotomy pain incidence. |
| Q36477630 | Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study |
| Q92717842 | Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study |
| Q39259363 | Electroacupuncture is not effective in chronic painful neuropathies |
| Q36803417 | Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review |
| Q37991227 | Epidemiology of neuropathic pain and its impact on quality of life |
| Q47416327 | Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. |
| Q34451586 | Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? |
| Q38964662 | Evaluating the Measurement Properties of the Self-Assessment of Treatment Version II, Follow-Up Version, in Patients with Painful Diabetic Peripheral Neuropathy. |
| Q42363959 | Evaluation of Effect of Nishamalaki on STZ and HFHF Diet Induced Diabetic Neuropathy in Wistar Rats |
| Q89996731 | Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis |
| Q37453720 | Evaluation of pain measurement practices and opinions of peripheral nerve surgeons |
| Q37943977 | Expert panel consensus recommendations for the pharmacological treatment of acute pain in the Middle East region |
| Q97520497 | Exploring Cancer Patients' Experiences of an Online Mindfulness-Based Program: A Qualitative Investigation |
| Q64059153 | Facilitation of neuropathic pain by the NPY Y1 receptor-expressing subpopulation of excitatory interneurons in the dorsal horn |
| Q37494833 | Framing new pathways in transformative exercise for individuals with existing and newly acquired disability |
| Q64109200 | Frequency and Risk Factors for Prolonged Opioid Prescriptions After Surgery for Brachial Plexus Injury |
| Q37761937 | Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region |
| Q30537158 | Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin |
| Q34083505 | Habituation to experimentally induced electrical pain during voluntary-breathing controlled electrical stimulation (BreEStim) |
| Q51843458 | Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population |
| Q41037722 | Heart Rate Variability: A Novel Modality for Diagnosing Neuropathic Pain after Spinal Cord Injury |
| Q51584858 | Impact of diabetic foot related complications on the Health Related Quality of Life (HRQol) of patients--a regional study in Spain. |
| Q34666193 | Impact of locomotion training with a neurologic controlled hybrid assistive limb (HAL) exoskeleton on neuropathic pain and health related quality of life (HRQoL) in chronic SCI: a case study (.). |
| Q38131417 | Incidence and predictors of neuropathic pain following breast surgery. |
| Q89747137 | Inflammation and nerve injury minimally affect mouse voluntary behaviors proposed as indicators of pain |
| Q35155806 | Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents |
| Q99711166 | Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain |
| Q48081716 | Living Well with Pain: Development and Preliminary Evaluation of the Valued Living Scale. |
| Q64917279 | Locally injected ivabradine inhibits carrageenan-induced pain and inflammatory responses via hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. |
| Q38368276 | Management of Neuropathic Pain Associated with Spinal Cord Injury |
| Q38012664 | Management of painful diabetic neuropathy: guideline guidance or jungle? |
| Q44685180 | Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand |
| Q53434279 | Methodological and clinical implications of a three-in-one Russian doll design for tracking health trajectories and improving health and function through innovative exercise treatments in adults with disability. |
| Q57492630 | Motor Control and Sensory Feedback Enhance Prosthesis Embodiment and Reduce Phantom Pain After Long-Term Hand Amputation |
| Q45052986 | Multiple mediation path model of pain's cascading influence on physical disability in individuals with SCI from Colombia, South America. |
| Q94338265 | Nerve growth factor for neuropathic pain |
| Q57142779 | Neuropathic Pain after Shoulder Arthroplasty: Prevalence, Impact on Physical and Mental Function, and Demographic Determinants |
| Q59510177 | Neuropathic pain |
| Q37883082 | Neuropathic pain in patients with upper-extremity nerve injury |
| Q48028241 | Neuropathic pain in people with cancer (part 1): incidence, manifestation, and assessment. |
| Q57815501 | Neuropathic pain modulation after spinal cord injury by breathing-controlled electrical stimulation (BreEStim) is associated with restoration of autonomic dysfunction |
| Q52321118 | Neuropathic pain: A patient-centred approach to measuring outcomes. |
| Q35245083 | Neuropathic pain: a personal case reflection on a critical incident |
| Q37404805 | Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy |
| Q36023078 | Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis |
| Q101403109 | Non-invasive neuromodulation effects on painful diabetic peripheral neuropathy: a systematic review and meta-analysis |
| Q24187769 | Non-pharmacological interventions for chronic pain in people with spinal cord injury |
| Q24235877 | Non-pharmacological interventions for chronic pain in people with spinal cord injury |
| Q36950068 | Novel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature Review |
| Q39890252 | Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy |
| Q24200179 | Opioids for neuropathic pain |
| Q36512144 | Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells |
| Q42643014 | Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice |
| Q40120453 | Pain assessment according to the International Spinal Cord Injury Pain classification in patients with spinal cord injury referred to a multidisciplinary pain center. |
| Q39166134 | Pain expectations in neuropathic pain: Is it best to be optimistic? |
| Q38187185 | Pain in chronic kidney disease: a scoping review |
| Q51889574 | Pain in multiple sclerosis: a clinical and instrumental approach. |
| Q33938295 | Pain intensity and its association with negative mood States in patients with spinal cord injury |
| Q36099014 | Pain modulation effect of breathing-controlled electrical stimulation (BreEStim) is not likely to be mediated by deep and fast voluntary breathing |
| Q34762806 | Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer |
| Q64066033 | Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnts (PDN-SCOPE): protocol for a multicentre cross-sectional registry study of clinical characteristics and treatment in China |
| Q34640959 | Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis |
| Q39146230 | Patient-reported neuropathic pain in adolescent and young adult cancer patients |
| Q37150367 | Patients with Rheumatoid Arthritis and Chronic Pain Display Enhanced Alpha Power Density at Rest |
| Q36646193 | Patients' perspectives on pain. |
| Q37739305 | Phenotyping and genotyping neuropathic pain |
| Q64972521 | Phenytoin Cream for the Treatment for Neuropathic Pain: Case Series. |
| Q38327044 | Placebo and nocebo effects in the neurological practice |
| Q39956407 | Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design |
| Q48486589 | Post-surgical neuropathic pain |
| Q38386200 | Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions |
| Q33751809 | Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review |
| Q90461181 | Preparation, Characterization and Dermal Delivery of Methadone |
| Q47105931 | Prevalence of Neuropathic Pain and Patient-Reported Outcomes in Korean Adults with Chronic Low Back Pain Resulting from Neuropathic Low Back Pain |
| Q33275388 | Prevalence of neuropathic pain after radical sacral chordoma resection: an observational cohort study with 10-year follow-up |
| Q43740500 | Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region |
| Q38416454 | Preventing and managing herpes zoster: key actions to foster healthy aging. |
| Q35907148 | Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system |
| Q43338838 | Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study |
| Q37073710 | Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy |
| Q47550763 | Psychological and Biomechanical Aspects of Patient Adaptation to Diabetic Neuropathy and Foot Ulceration. |
| Q88707123 | Quality of life after spinal cord injury: The impact of pain |
| Q37369001 | Randomized Controlled Trial in Advance Stage Breast Cancer Patients for the Effectiveness on Stress Marker and Pain through Sudarshan Kriya and Pranayam. |
| Q39212917 | Randomized, sham controlled trial of transcranial direct current stimulation for painful diabetic polyneuropathy |
| Q86605704 | Recent Developments in Neuropathic Pain Mechanisms: Implications for Treatment |
| Q24616897 | Recommendations for the pharmacological management of neuropathic pain: an overview and literature update |
| Q36758640 | Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin |
| Q35565643 | Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy |
| Q33299391 | Relationship of depression, disability, and family caregiver attitudes to the quality of life of Kuwaiti persons with multiple sclerosis: a controlled study |
| Q33624442 | Resilience and Vulnerability to Pain and Inflammation in the Hippocampus |
| Q98289415 | Retrospective Study on Ganglionic and Nerve Block Series as Therapeutic Option for Chronic Pain Patients with Refractory Neuropathic Pain |
| Q92702296 | Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain |
| Q37290744 | Sensory profile and its impact on quality of life in patients with painful diabetic polyneuropathy |
| Q36589206 | Serial anthropometry predicts peripheral nerve dysfunction in a community cohort |
| Q37575438 | Societal and patient burden of fibromyalgia syndrome |
| Q52662304 | Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms. |
| Q39166639 | St. John's Wort Potentiates anti-Nociceptive Effects of Morphine in Mice Models of Neuropathic Pain |
| Q37558014 | Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury |
| Q57491503 | Sudomotor Testing of Diabetes Polyneuropathy |
| Q39823245 | Swim therapy reduces mechanical allodynia and thermal hyperalgesia induced by chronic constriction nerve injury in rats |
| Q38123153 | Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury |
| Q36302168 | The Effect of Pulsed Radiofrequency Applied to the Peripheral Nerve in Chronic Constriction Injury Rat Model |
| Q58992398 | The Influence of Self-Efficacy on Mood States in People with Spinal Cord Injury |
| Q43705793 | The impact of early postoperative pain on health-related quality of life |
| Q39242390 | The lived experience of peripheral neuropathy after solid organ transplant |
| Q34949720 | The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica |
| Q37717947 | The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population |
| Q37644111 | The role of brain-derived neurotrophic factor in different animal models of neuropathic pain. |
| Q34502830 | Therapy using implanted organic bioelectronics. |
| Q38265422 | Topical analgesics for neuropathic pain in the elderly: current and future prospects |
| Q37682828 | Topical phenytoin for the treatment of neuropathic pain. |
| Q34320994 | Transcranial Direct Current Stimulation in Neuropathic Pain |
| Q33747265 | Treatment considerations for elderly and frail patients with neuropathic pain |
| Q33747271 | Treatment considerations for patients with neuropathic pain and other medical comorbidities |
| Q36196787 | Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster |
| Q34783788 | Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster - a case series. |
| Q38329620 | Treatment of painful diabetic peripheral neuropathy |
| Q37627047 | Trigeminal nerve injury-induced thrombospondin-4 up-regulation contributes to orofacial neuropathic pain states in a rat model |
| Q36507197 | Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain |
Search more.